|
Filed pursuant to Rule 497(a)(1) File No. 333-136918 Rule 482 ad |
Hercules Announces Offering of Common Stock
Palo Alto, Calif. —Nov. 30, 2006 — Hercules Technology Growth Capital, Inc. (NASDAQ: HTGC),
a leading specialty finance company providing debt and equity growth capital to venture capital and
private equity backed technology and life science companies, announced today that it plans a public
offering of approximately 5,500,000 shares of its common stock. In connection with the offering,
Hercules intends to grant the underwriters an option to purchase up to an additional 825,000 shares
to cover over-allotments, if any.
The net proceeds to Hercules Technology Growth Capital from the sale of the shares in the offering
are intended to repay indebtedness and for general corporate purposes.
Credit Suisse Securities (USA) LLC will act as Sole Book-Running Manager, JMP Securities LLC as
Co-Lead Manager and Ferris, Baker Watts, Inc. as Co-Manager of the offering.
This press release does not constitute an offer to sell or a solicitation of an offer to buy the
securities in this offering, nor shall there be any sale of these securities in any state in which
such offer, solicitation or sale would be unlawful prior to registration or qualification under the
securities laws of any such state.
A copy of the final prospectus to the offering may be obtained from Credit Suisse, Eleven Madison
Avenue, New York, NY 10010; Ferris, Baker Watts, Inc., 100 Light Street, Baltimore, MD 21202; or
JMP Securities LLC, 600 Montgomery Street, San Francisco, CA 94111.
About Hercules Technology Growth Capital, Inc.:
Founded in December 2003, Hercules Technology Growth Capital, Inc. is a NASDAQ traded specialty
finance company providing debt and equity growth capital to technology-related companies at all
stages of development. The Company primarily finances privately-held companies backed by leading
venture capital and private equity firms and also may finance certain publicly-traded companies.
Hercules’ strategy is to evaluate and invest in a broad range of ventures active in technology and
life science industries and to offer a full suite of growth capital products up and down the
capital structure to prospective clients ranging from early-stage growth to expansion stage
companies. The Company’s investments are originated through its principal office located in
Silicon Valley, as well as additional offices in the Boston, Boulder and Chicago areas. Providing
capital to publicly-traded or privately-held companies backed by leading venture capital and
private equity firms involves a high degree of credit risk and may result in potential losses of
capital.